|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.74 USD | +0.59% |
|
-0.46% | +25.14% |
| 07-13 | Mizuho Raises Price Target on Nurix Therapeutics to $34 From $30, Keeps Outperform Rating | MT |
| 07-10 | Nurix Therapeutics' Roche Deal Seen Driving Long-Term Upside, RBC Capital Markets Says | MT |
| Market Cap | 2.45B 2.15B 2B 1.84B 3.45B 237B 3.52B 23.85B 9.32B 115B 9.19B 9B 401B | P/E 2026 * |
-8.63x | P/E 2027 * | -10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.35B 1.19B 1.11B 1.02B 1.91B 131B 1.94B 13.18B 5.15B 63.81B 5.08B 4.97B 222B | EV / Sales 2026 * |
23.4x | EV / Sales 2027 * | 15.8x |
| Free-Float |
98.66% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Nurix Therapeutics, Inc.
| 1 day | +0.59% | ||
| 1 week | -0.46% | ||
| Current month | -2.14% | ||
| 1 month | +27.29% | ||
| 3 months | +42.75% | ||
| 6 months | +22.43% | ||
| Current year | +25.14% |
| 1 week | 22.45 |  | 24.17 |
| 1 month | 18.92 | | 25.08 |
| Current year | 14.01 | | 25.08 |
| 1 year | 8.2 | | 25.08 |
| 3 years | 4.22 | | 29.56 |
| 5 years | 4.22 | | 37.42 |
| 10 years | 4.22 | | 52.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Arthur Sands
CEO | Chief Executive Officer | 64 | 2014-09-17 |
Hans van Houte
DFI | Director of Finance/CFO | 60 | 2016-02-29 |
Seema Rogers
CTO | Chief Tech/Sci/R&D Officer | - | 2019-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Arthur Sands
BRD | Director/Board Member | 64 | 2014-09-17 |
David Lacey
CHM | Chairman | 73 | 2019-07-31 |
Julia Gregory
CHM | Chairman | 72 | 2024-05-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/2/26 | Fiscal year | Compliance Officer | 33,024 | 0.0319% | ||
| 6/25/26 | Fiscal year | Compliance Officer | 86,805 | 0.0839% | ||
| 6/25/26 | Sell | Chief Technology Officer | -5,394 | 0.0052% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.59% | -0.46% | +111.02% | +135.75% | 2.45B | |
| +1.23% | -3.08% | +53.96% | +87.98% | 55.27B | |
| +5.09% | +6.18% | +63.69% | +62.06% | 54.15B | |
| +0.72% | -2.19% | +4.36% | +409.54% | 23.11B | |
| +0.25% | +0.08% | -17.39% | -15.22% | 23.22B | |
| +1.03% | -0.76% | +40.14% | -3.59% | 20.33B | |
| -0.37% | +0.42% | +37.47% | -31.61% | 17.91B | |
| +0.87% | -2.80% | +37.96% | +600.00% | 15.76B | |
| -2.54% | -12.88% | +168.62% | +289.45% | 15B | |
| +1.22% | +0.18% | +25.14% | +182.63% | 13.82B | |
| Average | +0.81% | -0.44% | +52.50% | +171.70% | 24.1B | |
| Weighted average by Cap. | +1.55% | +1.17% | +47.14% | +138.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.74M 50.74M 47.16M 43.37M 81.31M 5.58B 82.88M 562M 220M 2.72B 217M 212M 9.46B | 96.4M 84.72M 78.73M 72.41M 136M 9.31B 138M 939M 367M 4.55B 362M 354M 15.79B |
| Net income | -303M -266M -247M -228M -427M -29.26B -435M -2.95B -1.15B -14.29B -1.14B -1.11B -49.64B | -249M -219M -203M -187M -351M -24.06B -358M -2.43B -948M -11.75B -935M -915M -40.82B |
| Net Debt | -1.1B -963M -895M -823M -1.54B -106B -1.57B -10.67B -4.17B -51.68B -4.11B -4.03B -180B | -923M -811M -754M -693M -1.3B -89.09B -1.32B -8.99B -3.51B -43.51B -3.46B -3.39B -151B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | US$23.74 | +0.59% | 965,869 |
| 26-07-22 | US$23.60 | +0.51% | 1,130,653 |
| 26-07-21 | US$23.48 | +3.39% | 961,277 |
| 26-07-20 | US$22.71 | -1.77% | 1,255,814 |
| 26-07-17 | US$23.12 | +0.22% | 794,891 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NRIX Stock
Select your edition
All financial news and data tailored to specific country editions
